Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: Reducing the potential morbidity of therapy
- 1 March 1997
- Vol. 49 (3) , 38-45
- https://doi.org/10.1016/s0090-4295(97)00168-4
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The potential for normal tissue dose reduction with neoadjuvant hormonal therapy in conformal treatment planning for stage C prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Neoadjuvant Hormonal Downsizing of Localized Carcinoma of the Prostate: Effects on the Volume of Normal Tissue IrradiationCancer Investigation, 1995
- Three-Dimensional Conformal Radiation Therapy in Localized Carcinoma of The Prostate: Interim Report of A Phase 1 Dose-Escalation StudyJournal of Urology, 1994
- Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Late rectal bleeding following combined x-ray and proton high dose irradiation for patients with stages T3–T4 prostate carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706International Journal of Radiation Oncology*Biology*Physics, 1991
- Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal doseInternational Journal of Radiation Oncology*Biology*Physics, 1990
- The effect of dose on local control of prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Tumor control in definitive irradiation of localized carcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958